Bharat Parenterals Announces Dividend and Subsidiary Funding Ahead of AGM

Dividend of Rs 1 per share declared; Rs 75 crore in funding for Innoxel Lifesciences proposed.

Reader Takeaway: Shareholders will vote on a Rs 1 dividend and significant subsidiary loans at the September 19 AGM.

What just happened

Bharat Parenterals Limited has announced its 33rd Annual General Meeting (AGM) to be held via video conference on September 19, 2026. The meeting will address several core corporate actions, including the finalization of financial statements and the approval of a dividend payout for the fiscal year ended March 31, 2026.

Dividend and Key Dates

The company has recommended a final dividend of Rs 1 per equity share. To qualify for this payout, shareholders must hold the stock by the record date of September 12, 2026. The payout is scheduled to be processed on or before October 19, 2026.

Subsidiary Support

A primary agenda item is the approval of a material related party transaction involving the company’s 55.89% subsidiary, Innoxel Lifesciences Private Limited. The board is seeking shareholder clearance for unsecured loans and advances of up to Rs 75 crore to bolster the subsidiary's working capital and operational needs.

Governance and Remuneration

The AGM will formalize the re-appointment of Mr. Hemang Shah as Executive Director for a five-year term ending in 2031. His annual remuneration is proposed to increase to Rs 36 Lakhs from the previous Rs 28.50 Lakhs. Additionally, the company will seek approval for the remuneration of its cost auditor, M/s. Chetan Gandhi & Associates, set at Rs 75,000 for the upcoming fiscal year.

What to track next

Investors should track the voting outcome regarding the subsidiary loan proposal, as this represents a significant capital commitment within the Bharat Parenterals group structure.